Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (461-470 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|January 10, 2018
Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patientsYong Yang, Baoyang Luo, Yong An, et al.
Oncotarget|January 10, 2018
Microwave ablation <i>versus</i> radiofrequency ablation for the treatment of pulmonary tumorsFeng Shi, Guangxiao Li, Zejian Zhou, et al.
Oncotarget|January 10, 2018
Nanoparticles and female reproductive system: how do nanoparticles affect oogenesis and embryonic developmentCong-Cong Hou, Jun-Quan Zhu
Oncotarget|January 10, 2018
Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumerationLei Wang, Coraline Dumenil, Catherine Julié, et al.
Oncotarget|March 24, 2018
Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cellsHua Chen, Jacson Shen, Edwin Choy, et al.
Oncotarget|March 24, 2018
Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cellsHsin-Pao Chen, Yung-Kuo Lee, Shih Yin Huang, et al.
Oncotarget|March 24, 2018
The metal-nonoate Ni(SalPipNONO) inhibits <i>in vitro</i> tumor growth, invasiveness and angiogenesisValerio Ciccone, Martina Monti, Enrico Monzani, et al.
Oncotarget|March 24, 2018
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin<sup>®</sup> protein MP0250: a preclinical studyLuigia Rao, Kim De Veirman, Donato Giannico, et al.
Oncotarget|March 24, 2018
Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasisMichael P Marciel, Vedbar S Khadka, Youping Deng, et al.
Oncotarget|March 24, 2018
The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression <i>in vitro</i>Laura N Eadie, Verity A Saunders, Susan Branford, et al.
Pageof 2,673

Showing results (461-470 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|January 10, 2018
Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patientsYong Yang, Baoyang Luo, Yong An, et al.
Oncotarget|January 10, 2018
Microwave ablation <i>versus</i> radiofrequency ablation for the treatment of pulmonary tumorsFeng Shi, Guangxiao Li, Zejian Zhou, et al.
Oncotarget|January 10, 2018
Nanoparticles and female reproductive system: how do nanoparticles affect oogenesis and embryonic developmentCong-Cong Hou, Jun-Quan Zhu
Oncotarget|January 10, 2018
Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumerationLei Wang, Coraline Dumenil, Catherine Julié, et al.
Oncotarget|March 24, 2018
Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cellsHua Chen, Jacson Shen, Edwin Choy, et al.
Oncotarget|March 24, 2018
Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cellsHsin-Pao Chen, Yung-Kuo Lee, Shih Yin Huang, et al.
Oncotarget|March 24, 2018
The metal-nonoate Ni(SalPipNONO) inhibits <i>in vitro</i> tumor growth, invasiveness and angiogenesisValerio Ciccone, Martina Monti, Enrico Monzani, et al.
Oncotarget|March 24, 2018
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin<sup>®</sup> protein MP0250: a preclinical studyLuigia Rao, Kim De Veirman, Donato Giannico, et al.
Oncotarget|March 24, 2018
Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasisMichael P Marciel, Vedbar S Khadka, Youping Deng, et al.
Oncotarget|March 24, 2018
The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression <i>in vitro</i>Laura N Eadie, Verity A Saunders, Susan Branford, et al.
Pageof 2,673